论文部分内容阅读
11月3日,《纽约时报》报道了世界卫生组织总干事陈冯富珍近日在西非国家贝宁的一次区域性会议发表的演讲。演讲中,她对生物制药业进行了强烈批评,指出制药产业的逐利性和对公共卫生的忽视是埃博拉疫苗迟迟没有研发出来的重要原因之一。自1976年,埃博拉病毒首次在民主刚果和扎伊尔等国发现开始,由于疫情集中在这些购买力不足的非洲国家流行,使得众多具备研发能力的生物制药公司普遍缺乏对埃博拉
On November 3, the New York Times reported on a speech delivered recently by WHO Director-General Margaret Chan at a regional conference in West African country Benin. In her speech, she strongly criticized the biopharmaceutical industry, pointing out that the profitability of the pharmaceutical industry and neglect of public health are some of the important reasons for the late development of the Ebola vaccine. Since the first discovery of the Ebola virus in 1976 in countries such as DRC and Zaire, epidemics have been endemic in these less-costly African countries, leaving many R & D-enabled biopharmaceutical companies with a general lack of access to Ebola